← Eichor
Condition: Giant Lymph Node Hyperplasia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Giant Lymph Node Hyperplasia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Italian Multicenter Retrospective Observational Study to Assess Effectiveness and Safety of Siltuximab for Patients w
Phase N/A · 12 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06720870AutoInflammatory Disease Alliance Registry (AIDA)
Phase N/A · 112 location(s) · University of Siena · NCT05200715Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Phase N/A · 8 location(s) · AIDS Malignancy Consortium · NCT05663502Natural History of KSHV-Associated Multicentric Castleman s Disease
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT04968288Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cance
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00006518Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT03300830A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
Phase N/A · 1 location(s) · Peking University First Hospital · NCT05283993International Registry for Patients With Castleman Disease
Phase N/A · 1 location(s) · University of Pennsylvania · NCT02817997Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Ass
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06052618Registry for Adults With Plasma Cell Disorders (PCD's)
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT03717844Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Diseas
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05907759Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease
Phase 2 · 1 location(s) · University of Pennsylvania · NCT07085039
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.